These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5736586)

  • 21. Analysis of the cardiodepressor action of 3-nitropropionic acid.
    Castillo C; Reyes G; Rosas-Lezama MA; Valencia I; Hong E
    Proc West Pharmacol Soc; 1994; 37():41-2. PubMed ID: 7984666
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Revenko SV; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2004; 67(4):26-9. PubMed ID: 15500041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of complex therapy of ventricular arrhythmias with emoxipin and preductal in combination with antiarrhythmic agents].
    Kotliarov AA; Mosina LM; Kairakina TN; Chibisov SM; Kulikov SI
    Klin Med (Mosk); 2007; 85(12):22-6. PubMed ID: 18318161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ajmaline challenge in Brugada syndrome.
    Mandelburger D; Teubl A; Röggla G
    Resuscitation; 2007 Aug; 74(2):393-4. PubMed ID: 17521798
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects].
    Lévy S
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():29-35. PubMed ID: 6803700
    [No Abstract]   [Full Text] [Related]  

  • 27. [Stimulus-dependent blockade of the Na channels of isolated myocardial cells in the rat by the anti-arrhythmia agent N-propyl ajmaline (neogiluritmal)].
    Zil'berter IuI; Khodorov BI; Shubert B
    Biull Eksp Biol Med; 1983 Apr; 95(4):55-8. PubMed ID: 6299433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methodological critiques of protocols of clinical studies of anti-arrhythmia agents].
    Boissel JP; Leizorovicz A; Peyrieux JC; Alamzecery Y
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():91-6. PubMed ID: 6803707
    [No Abstract]   [Full Text] [Related]  

  • 29. Anxiolytic properties of the antipsychotic alkaloid alstonine.
    Costa-Campos L; Dassoler SC; Rigo AP; Iwu M; Elisabetsky E
    Pharmacol Biochem Behav; 2004 Mar; 77(3):481-9. PubMed ID: 15006458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the activity of anti-arrhythmia agents in calcium chloride-induced arrhythmia in mice].
    Gorbunova VV; Gorbunov NP
    Farmakol Toksikol; 1983; 46(3):48-50. PubMed ID: 6861988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in arrhythmology].
    Furlanello F; Bettini R; Dal Forno P; Vergara G; Stefenelli C; Zuechi S; Inama G; Disertori M
    G Ital Cardiol; 1981; 11 Suppl 1():202-53. PubMed ID: 7035271
    [No Abstract]   [Full Text] [Related]  

  • 32. [Euchronotropic and eubatmotropic effects of hexobendine. I. Introduction to its anti-arrhythmic action].
    Martínez-Muñoz A
    Rev Esp Cardiol; 1969 Jan; 22(1):57-66. PubMed ID: 5799323
    [No Abstract]   [Full Text] [Related]  

  • 33. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 34. Melohenines A and B, two unprecedented alkaloids from Melodinus henryi.
    Feng T; Cai XH; Li Y; Wang YY; Liu YP; Xie MJ; Luo XD
    Org Lett; 2009 Nov; 11(21):4834-7. PubMed ID: 19863145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic profile of alstonine: ethnopharmacology of a traditional Nigerian botanical remedy.
    Costa-Campos L; Elisabetsky E; Lara DR; Carlson TJ; King SR; Ubillas R; Nunes DS; Iwu MM; Nkemjika CO; Ozioko A; Agwu CO
    An Acad Bras Cienc; 1999; 71(2):189-201. PubMed ID: 10412490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
    Scherr D; Brunner G; Kaufmann P; Lercher P; Lueger A; Rotman B; Smolle KH; Stark G; Klein W; Krejs GJ
    Intensive Care Med; 2002 Jun; 28(6):789-92. PubMed ID: 12107687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
    Wyse DG
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):132-3. PubMed ID: 16265454
    [No Abstract]   [Full Text] [Related]  

  • 38. Localized and dynamic repolarization alternans in Ajmaline accentuated Brugada syndrome.
    Raviña T; Raviña M; Lapuerta JA
    Int J Cardiol; 2006 Jan; 106(1):119-22. PubMed ID: 16321676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute therapy of tachycardic arrhythmias. 1: Anti-arrhythmia agents, supraventricular tachycardia].
    Gonska BD; Rab J
    Fortschr Med; 1995 Feb; 113(6):73-6. PubMed ID: 7721225
    [No Abstract]   [Full Text] [Related]  

  • 40. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.